Plain-English translation of NCT07748533 on ClinicalTrials.gov ā Ā· Source last updated Ā· How we translate trials
Phase 1 ā Testing in a small group (usually 20ā80 people) to find a safe dose and watch for side effects.
China
Sponsor
Juventas Cell Therapy Ltd.
Enrollment target
~9 participants
Started
July 2026
Primary completion
September 2028
Age range
18 Years ā 75 Years
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary ā some teams are faster than others.
Central contact
Xiaofeng PAN
Juventas Cell Therapy Ltd.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first ā no email needed to get started.